- Comunicados Internet
EP Europa Press Thu, 09 Sep 2004 3:07 AM PDT
Recent studies have revealed markedly improved efficacy with pegylated interferon compared with conventional non-pegylated interferon, providing inhibition of viral replication in nearly 50% of patients. Combination therapies using various drugs are currently under evaluation, although the optimal therapeutic approach remains to be determined.
[Non-text portions of this message have been removed]